Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
BELLICUM PHARMACEUTICALS, INC (BLCM)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/05/2023 |
4
| Daly James M (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Exercised 60,414 shares
@ $0 |
|
01/05/2023 |
4
| DAVIS STEPHEN (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Exercised 74,739 shares
@ $0 |
|
01/05/2023 |
4
| Huber Reid M (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Exercised 87,196 shares
@ $0 |
|
01/05/2023 |
4
| Stonehouse Jon P (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Exercised 121,452 shares
@ $0 |
|
01/05/2023 |
4
| Klimovsky Judith V (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Exercised 60,414 shares
@ $0 |
|
09/02/2022 |
4
| Klimovsky Judith V (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Exercised 35,082 shares
@ $0 |
|
09/02/2022 |
4
| DAVIS STEPHEN (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Exercised 43,400 shares
@ $0 |
|
09/02/2022 |
4
| Daly James M (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Exercised 35,082 shares
@ $0 |
|
09/02/2022 |
4
| Huber Reid M (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Exercised 46,489 shares
@ $0 |
|
09/02/2022 |
4
| Stonehouse Jon P (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Exercised 60,580 shares
@ $0 |
|
08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/16/2022 |
4
| Fair Richard A. (President and CEO) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Granted 400,000 options to buy
@ $1.44, valued at
$576k
|
|
06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2022 |
4
| Klimovsky Judith V (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Granted 15,000 options to buy
@ $1.11, valued at
$16.7k
|
|
06/16/2022 |
4
| Daly James M (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Granted 15,000 options to buy
@ $1.11, valued at
$16.7k
|
|
06/16/2022 |
4
| Huber Reid M (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Granted 15,000 options to buy
@ $1.11, valued at
$16.7k
|
|
01/06/2022 |
4
| Huber Reid M (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Exercised 19,494 restricted stock units
@ $0 |
|
01/06/2022 |
4
| BROWN JAMES F (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Exercised 28,384 restricted stock units
@ $0 |
|
01/06/2022 |
4
| Stonehouse Jon P (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Exercised 21,504 restricted stock units
@ $0 |
|
01/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/06/2022 |
4
| Klimovsky Judith V (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Exercised 14,036 restricted stock units
@ $0 Exercised 566 restricted stock units
@ $0 |
|
01/06/2022 |
4
| DAVIS STEPHEN (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Exercised 18,715 restricted stock units
@ $0 |
|
12/02/2021 |
4
| Scripture Charity (Chief Development Officer) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Granted 150,000 options to buy
@ $1.73, valued at
$259.5k
|
|
08/16/2021 |
4
| Fair Richard A. (President and CEO) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Granted 265,000 options to buy
@ $2.91, valued at
$771.2k
|
|
07/07/2021 |
4
| Stonehouse Jon P (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Granted 6,500 options to buy
@ $3.05, valued at
$19.8k
|
|
07/07/2021 |
4
| Klimovsky Judith V (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Granted 6,500 options to buy
@ $3.05, valued at
$19.8k
|
|
07/07/2021 |
4
| Huber Reid M (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Granted 6,500 options to buy
@ $3.05, valued at
$19.8k
|
|
07/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/07/2021 |
4
| Daly James M (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Granted 6,500 options to buy
@ $3.05, valued at
$19.8k
|
|
07/07/2021 |
4
| BROWN JAMES F (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Granted 6,500 options to buy
@ $3.05, valued at
$19.8k
|
|
07/06/2021 |
4
| Klimovsky Judith V (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Granted 566 restricted stock units
@ $0 |
|
07/06/2021 |
4
| Daly James M (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns:
| Granted 809 restricted stock units
@ $0 |
|
01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|